Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.
NYS Entity Status
NYS Filing Date
AUGUST 11, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - GILROSE PHARMACEUTICALS, LLC
Around the Web
- Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
Monday Oct 16, 2017
- A High School Without Textbooks
Tuesday Oct 8, 2013
Archbishop Stepinac High School, in White Plains, N.Y., is one of the first schools in the U.S. to do away with paper textbooks. Instead, the all-boys prep school requires students to use tablets and laptops in class. (Data provided by Statista.com.)
- The Strange Case of Martin Shkreli Is Wrapping Up
By STEPHANIE CLIFFORD - Wednesday Jul 26, 2017
An unusual trial has featured victims who actually made money and defense lawyers who paint their client as an erratic misfit and want more victims to testify.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- The Rebuilding Years, Post-Sandy
By THE NEW YORK TIMES and JONAH MARKOWITZ - Sunday Oct 29, 2017
Those affected by Hurricane Sandy five years ago shared how the storm changed their lives physically, emotionally and financially, and how things have changed for the better since.